|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Operating expenses: | ||||
| Research and development | ||||
| General and administrative | ||||
| Total operating expenses | ||||
| Loss from operations | ||||
| Other income (expense), net: | ||||
| Interest income | ||||
| Other expense, net | ||||
| Total other income, net | ||||
| Net loss | ||||
| Other comprehensive (loss) income: | ||||
| Unrealized (loss) gain on available-for-sale investments, net of tax | ||||
| Comprehensive loss | ||||
| Net loss per share—basic | ||||
| Net loss per share—diluted | ||||
| Weighted-average common stock outstanding—basic | ||||
| Weighted-average common stock outstanding—diluted | ||||
Loading...